US Patent Issued to Nuvalent on April 15 for "Heteroaromatic macrocyclic ether chemotherapeutic agents" (American, Chinese Inventors)

ALEXANDRIA, Va., June 5 -- United States Patent no. 12,275,742, issued on April 15, was assigned to Nuvalent Inc. (Cambridge, Mass.).

"Heteroaromatic macrocyclic ether chemotherapeutic agents" was invented by Joshua Courtney Horan (Cambridge, Mass.), Xinxing Tang (Pudong, China), Scot Richard Mente (Cambridge, Mass.), Henry Efrem Pelish (Cambridge, Mass.), Matthew D. Shair (Cambridge, Mass.) and Anupong Tangpeerachaikul (Cambridge, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are heterocyclic heteroaromatic macrocyclic ether compounds, pharmaceutically acceptable salts of the compounds and pharmaceutical compositions thereof. Also disclosed are methods of treating or preventing cancer using...